Abstract
An interpretation of previous and recent observation on calcium salt crystallization and calcium stone formation provide the basis for formulation of a hypothetical series of events leading to calcium oxalate (CaOx) stone formation in the urinary tract. The various steps comprise a primary precipitation of calcium phosphate (CaP) at high nephron levels, establishment of large intratubular and/or interstitial (sub-epithelial) aggregates of CaP. These crystal masses subsequently might be dissolved during periods with low urine pH. On the denuded surface of subepithelial or intratubularly trapped CaP, release of calcium ions can result in very high ion-activity products of CaOx, particularly during simultaneous periods with peaks of CaOx supersaturation. Crystals of CaOx may result from nucleation in the macromolecular environment surrounding the apatite crystal phase. In the presence of low pH, low citrate and high ion-strength of urine, formation of large CaOx crystal masses can be accomplished by self-aggregation of Tamm–Horsfall mucoprotein. Following dislodgment of the initially fixed CaOx stone embryo, the further development into to clinically relevant stone is accomplished by CaOx crystal growth and CaOx crystal aggregation of the retained stone material. The latter process is modified by a number of inhibitors and promoters present in urine. The retention of the stone is a consequence of anatomical as well as hydrodynamic factors.
Similar content being viewed by others
References
Tiselius HG (1996) Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippincott-Raven Publishers, Philadelphia, pp 33–64
Wendt-Nordahl G, Evan AP, Spahn M, Knoll T (2008) Calcium oxalate stone formation. New pathogenetic aspects of an old disease. Urologe A 47:540–544
Hess B, Kok DJ (1996) Nucleation, growth and aggregation of stone-forming crystals. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippincott-Raven Publishers, Philadelphia, pp 3–32
Achilles W (1997) In vitro crystallization systems for the study of urinary stone formation. World J Urol 244–251
Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB (1978) Risk factors n calcium stone disease of the urinary tract. Br J Urol 50:449–454
Nancollas GH (1983) Crystallization theory relating to urinary stone formation. World J Urol 1:131–137
Khan S, Kok D (2004) Modulators of urinary stone formation. Front Biosci 9:1450–1482
Coe FL, Parks JH, Nakagawa Y (1991) Protein inhibitors of crystallization. Semin Urol 11:98–109
Scurr DS, Robertson WG (1986) Modifiers of calcium oxalate crystallization found in urine. III studies on the role of Tamm–Horsfall mucoprotein and ionic strength. J Urol 136:505–507
Roberston WG, Scurr DS, Bridge M (1981) Factors influencing the crystallisation of calcium oxalate—critique. J Cryst Growth 53:182–194
Lieske JC, Walsh-Reitz MM, Toback FG (1992) Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol (Renal Electrolyte Physiol) 262:F622–F630
Yuen J, Gohel M, Poon N, Shum D, Tam PA, Au DW (2010) The initial and subsequent inflammatory events during calcium oxalate lithiasis. Clin Chim Acta 411:15–16
Vervaet B, Vehulst A, De Broe M, D′Haese P (2010) The tubular epithelium in the initiation and course of intratubular nephrocalcinosis. Urol Res 38:249–256
Evan AP, Lingeman JE, Coe FL, Worcester EM (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111–119
Matlaga BR, Kim JCW, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Lingeman JE (2006) Endoscopic evidence of calculus attachment to Randal’s plaque. J Urol 175:1720–1724
Randall A (1940) Papillary pathology as a precursor of primary renal calculus. J Urol 44:580
Smith LH, Werness PG (1983) Hydroxyapatite—the forgotten crystal in calcium urolithiasis. Trans Am Clin Chem Assoc 95:183–190
Öhman S, Larsson L, Tiselius HG (1992) Clinical significance of phosphate in calcium oxalate renal stones. Ann Clin Biochem 29:59–63
Leusmann DB, Blanschke R, Schwandt W (1990) Results of 5035 stone analyses: a contribution to epidemiology of urinary stone disease. Scand J Urol Nephrol 24:205–210
Tiselius HG, Larsson L (1993) Calcium phosphate—an important crystal phase in patients with recurrent calcium stone formation? Urol Res 21:175–180
Grases F, March JG, Conte A, Costa-Bautzá A (1993) New aspects on the composition, structure and origin of calcium oxalate monohydate calculi. Eur Urol 24:381–386
Fernandez-Conde M, Alcover J, Barastegui C, Carretero P (1995) Calculi of papillary origin. Ann Urol (Paris) 29:351–354
Prien EL Sr (1975) The riddle of Randall′s plaques. J Urol 114:500–507
Miller NL, Evan AP, Lingeman JE (2007) Pathogenesis of renal calculi. Urol Clin North Am 34:295–313
de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, van’t Noordende JM, Schröder FH (1995) Etiology of calcium oxalate nephrolithiasis in rats. II. Scanning Microsc 9:124–125
Evan AP (2009) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25:831–841
Coe FL, Evan AP, Lingeman JE, Worcester EM (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239–247
Ahlstrand C, Tiselius HG, Larsson L (1984) Studies on crystalluria in calcium oxalate stone formers. Urol Res 12:103–106
Kok DJ (1996) Free and fixed particle mechanism, a review. Scanning Microsc 10:471–486
Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847–854
Finlayson B, Reid F (1978) The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442–448
Kok DJ, Khan SR (1995) Chances for free or fixed particle mechanism. In: Rao PN, Kavanagh JP, Tiselius HG (eds) Urolithiasis Consensus and Controversies. Lithtripter Unit, Withington Hospital, Manchester, pp 431–432
Crassweller PO, Brandes L, Katrizoglou A, Oreopoulos DG (1979) Studies on crystalluria in recurrent calcium lithiasis. Can J Surg 22:527–529
Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Cryst Growth 53:166–181
Adamthwaite DN (1983) Urinary particulate activity in urinary calculus disease. Br J Urol 55:95–99
Asplin J, DeGanello S, Nakgawa YN, Coe F (1991) Evidence for calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604–F613
Tiselius HG, Hojgaard I (1999) Some aspects of the intratubular precipitation of calcium salts. J Am Soc Nephrol 10:S373–S375
Asplin JR, Mandel NS, Coe FL (1996) Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604–F613
Luptak J, Bek-Jensen H, Fornander AM, Hojgaard I, Nilsson MA, Tiselius HG (1994) Crystallization of calcium oxalate and calcium phosphate at supersaturation levels corresponding to those in different parts of the nephron. Scanning Microsc 8:47–62
Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1996) Crystallisation during volume reduction of solutions with an ion-composition corresponding to that in the distal tubuli. Scanning Microsc 10:487–498
Berg C, Tiselius HG (1986) The effect of pH on the risk of calcium oxalate crystallization in urine. Eur Urol 12:59–61
Christoffersen MR, Christoffersen J, Kibalczyc W (1990) Apparent solubilities of two amorphous calcium phosphates and of octa calcium phosphate in the temperature range 30–42°C. J Cryst Growth 106:349–354
DeGanello S, Asplin J, Coe FL (1990) Evidence that the fluid in the thin segment of the loop of Henle normally is supersaturated and forms poorly crystallized hydroxyapatite that can initiate renal stones. (Abstract). Kidney Int 37:472
Koutsoukos PG, Nancollas GH (1981) Crystal growth of calcium phosphates—epitaxial considerations. J Cryst Growth 53:10–19
Hojgaard I, Tiselius HG (1999) Crystallisation in the nephron. Urol Res 27:397–403
Lundager-Madsen HE, Christensson F (1991) Precipitation of calcium phosphate at 40°C from neutral solution. J Cryst Growth 114:613–618
Baumann JM, Ackermann D, Affolter B (1989) The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs. Urol Res 17:153–155
Khori KMK, Ishikawa Y, Katayama Y, Takada M, Katoh Y, Kataoka K, Iguchi M, Kurita T (1991) Relationship between metabolic acidosis and calcium phosphate stone formation in women. Int Urol Nephrol 23:307–316
Evan AP, Lingeman J, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaques of patients with nephrolithiasis begins in basement membranes of the loop of Henle. J Clin Invest 111:602–605
Sepe V, Adamo G, La Fianza A, Libetta C, Giuliano MG, Soccio G (2006) Henle loop basement membrane as initial site for Randall plaque formation. Am J Kidney Dis 48:706–711
Tiselius HG (1996) Estimated levels of superstauration with calcium phosphate and calcium oxalate in the distal tubuli. Urol Res 25:153–159
Tiselius HG, Hallin A, Lindbäck B (2001) Crystallisation properties in stone forming and normal subjects urine diluted using a standardized procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct. Urol Res 29:75–82
Kok DJ, Schell-Feith EA (1999) Risk factors for crystallisation in the nephron: the role of renal develpment. J Am Soc Nephrol 10:S364–S370
Hering F, Lueoend G, Briellmann T, Seiler H, Guggenheim H, Rutishauser G (1988) Stone formation in the human kidney. In: Walker VR, Sutton RL, Cameron B, Pak CYC, Roberston WG (eds) Urolithiasis. Plenum Press, New York, pp 73–74
Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Worcester EM (2009) Intratubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int 76:1081–1088
Resnick MI, Boyce WH (1978) Sperical calcium bodies in stone-forming urine. Invest Urol 15:449–451
Achilles W, Jockel U, Schaper A, Ulshofer B, Riedmiller H (1994) Formation of urinary stones in vitro: growth of calcium oxalate on spherulites of calcium phosphate in gel. In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis, vol 2. Plenum Press, New York, pp 161–165
Fan J, Chandoke PS (1999) Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique. J Urol 161:1685–1688
Borghi L, Meschi T, Guerra A, Bergamaschi E, Mutti A, Novarini A (1995) Effect of urinary acromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Clin Chim Acta 239:1–11
Carvalho M, Mulinari R, Nakagawa Y (2002) Role of Tamm–Horsfall protein and uromodulin in calcium oxalate crystallization. Br J Med Biol Res 35:1165–1172
Maslamani S, Glenton PA, Khan SR (2000) Changes in urine macromolecular composition during processing. J Urol 164:230–236
Gorski JP (1992) Acidic phosphoproteins from bone matrix: a structural rationalization of their role in biomineralization. Calif Tissue Int 50:391–396
Fasano JM, Khan S (2001) Intratubular crystallisation of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int 59:169–178
Talham DR, Backov R, Benitez IO, Sharbaugh DM, Whipps S, Khan SR (2006) Role of lipids in urinary stones: studies of calcium oxalate precipitation at phospholipid langmuir monolayers. Langmuir 22:2450–2456
Wuthier RE (1973) The role of phospholipids in biological calcification: Distribution of phospholipase activity in calcifying epiphyseal cartilage. Clin Orthoped Relat Res 90:191–200
Wang L, Guan X, Tang R, Hoyer J, Wierzbicki A, De Yorero J, Nancollas G (2008) Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization. J Phys Chem B 112:9151–9157
Gebauer D, Völkel A, Cölfen H (2008) Stable prenucleation calcium carbonate clusters. Science 322:1819–1822
Bauman JM, Affolter B, Caprez U, Henze U, Lauper D, Maier F (2001) Hydroxyapatite induction and secondary aggregation, two important processes in calcium stone formation. Urol Res 29:417–422
Nakagawa Y, Ahmed MA, Hall SL, Deganello S, Coe FL (1987) Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal gowth. J Clin Invest 79:1782–1787
Coe FL, Nakagawa Y, Parks JH (1991) Inhibitors within the nephron. Am J Kidney Dis 17:407–413
Ryall RL, Harnett RM, Hibbers CM, Edyvane KA, Marshall VR (1991) Effects of chondroitin sulphate, human serum albumin and Tamm–Horsfall mucoprotein on calcium oxalate crystallizaion in undiluted human urine. Urol Res 19:181–188
Khan SR (1995) Experimental calcium oxalate nephrolithiasis and the formation human urinary stones. Scanning Microsc 9:89–100
Khan SR, Hackett RL (1991) Retention of calcium oxalate crystals in renal tubules. Scanning Microsc 5:711–712
Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaque of patients with nephrolithiasis begins in the basement membranes of the thin loops of Henle. J Clin Invest 111:607–616
Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stones formation. Urol Res 38:147–160
Pak CYC (1981) Potential etiologic role of brushite in the formation of calcium (renal) stones. J Cryst Growth 53:202–208
Matlaga BR, Coe FL, Evans APELJ (2007) The role of Randall’s plaque in the pathogenesis of calcium stones. J Urol 177:31–38
Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec 290:1315–1323
Evan AP, Lingeman J, Coe FL, Worcester E (2006) Randall’s plaque: pathogenesis and role in calcium calcium oxalate nephrolithiasis. Kidney Int 69:1313–1318
Kleinman J, Alatalo L, Beshensky A, AE J (2008) Acidic polyanion poly(acrylic acid) prevents calcium oxalate deposition. Kidney Int 74:919–924
Fleisch H (1978) Inhibitors and prompters of stone formation. Kidney Int 13:361–371
Sutor DJ, Percival JM, Piper KAJ (1979) Urinary inhibitors of calcium phosphate formation: the inhibitory activity in artificial urines. Br J Urol 51:1–5
Györy AZ, Ashby R (1999) Calcium salt urolithiasis. Review of theory for diagnosis and management. Clin Nephrol 51:197–208
Kok D, Papapoulos SE, Blomen LJMJ, Bijvoet OLM (1988) Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kidney Int 34:346–350
Kok D, Papapoulos SE, Bijvoet OLM (1986) Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1056–1058
Tiselius HG (1984) Urinary pH and calcium oxalate crystallization. In: Fortschritte der Urolige und Nephrologie. Pathogenese und Klinik der Harnsteinae X. (eds Vahlensieck W, Gasser, G). Steinkopff, Darmstadt 22:184–187
Moreno EC, Varughese K (1981) Crystal growth of calcium apatites from dilute solutions. J Cryst Growth 53:20–30
Meyer JL, Smith LH (1975) Growth of calcium oxalate crystals. II Inhibition by natural crystal growth inhibitors. Invest Urol 13:36–39
Morse RM, Resnick MI (1988) A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. J Urol 139:869–873
Curreri PA, Onoda G, Finlayson B (1981) A comparative appraisal of adsorption of citrate on whewellite seed crystals. J Cryst Growth 53:209–214
Robertson WG, Peacock M, Marshall RW, Marshall DHCNBE (1976) Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. New Engl J Med 294:249–252
Atmani F, Glenton PA, Khan SR (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201–207
Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1998) The influence of hydroxyapatite seed on the crystallisation induced by volume reduction of solutions with an ion composition corresponding to that in the distal tubule at different pH levels. Scand J Urol Nephrol 32:311–319
Mandel N, Mandel G (1990) Epitaxis in renal stones. In: Wickham JA, Buck AC (eds) Renal tract stone. Churchill Livingstone, London, pp 87–101
Khan SR, Glenton PA (2010) Experimental induction of calcium oxalate nephrolithiasis in mice. J Urol 184:1189–1196
Embery G, Rees S, Hall R, Rose K, Waddington R, Shellis P (1998) Calcium- and apatite-binding properties of glucuronic acid-rich and iduronic acid-rich glycosmanoglycans and proteoglycans. Eur J Oral Sci 106(suppl 1):267–273
Hess B (1994) Tamm–Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 20:393–398
Gault MH, Chafe LL, Morgan JM, Parfrey PS, Harnett JD, Walsh EA, Prabhakaran VM, Dow D, Colpitts A (1991) Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine 70:345–359
Grover PK, Thurgood LA, Fleming DE, van Bronswijk W, Wang T, Ryall RL (2008) Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured cells. Am J Physiol Renal Physiol 294:F355–F361
Tiselius HG, Lindbäck B, Fornander AM, Nilsson MA (2009) Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation. Urol Res 37:181–192
Leal JJ, Finlayson B (1977) Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces. Invest Urol 14:278–283
Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R (1979) The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci 57:285–288
Langley SEM, Fry CH (1997) The influence of pH on urinary ionized [Ca2+]: differences between urinary tract stone formers and normal subjects. Br J Urol 79:8–14
Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MAS (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 151:571–574
Elliot JS, Sharp R, Lewis L (1959) Urinary pH. J Urol 81:339–343
Hallson PC, Rose GA (1977) Seasonal variations in urinary crystals. Br J Urol 49:277–284
Wu W, Gerard D, Nancollas G (1999) Nucleation at surfaces: the importance of interfacial energy. J Am Soc Nephro 10(suppl 14):S355–S358
Ahlstrand C, Tiselius HG (1987) Urine composition and stone formation during treatment with acetazolamide. Scand J Urol Nephrol 21:225–228
Höjgaard I, Fornander AM, Nilsson MA, Tiselius HG (1999) Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: influence of hydroxyapatite seed crystals an urinary macromolecules. Urol Res 27:417–425
Landis W, Silver F (2009) Mineral deposition in the extracellular matrices of vertebrate tissues: identification of possible apatite nucleation sites on type I collagen. Cells Tissues Organs 189:20–24
Atmani F, Opalko FJ, Khan SR (1996) Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine. Urol Res 24:45–50
Gul A, Res P (2007) Models for protein binding to calcium oxalate surfaces. Urol Res 35:63–71
Tiselius HG (1999) Factors influencing the course of calcium oxalate stone disease. Eur Urol 36:363–370
Tiselius HG, Bek-Jensen H, Fornander AM, Nilsson MA (1995) Crystallisation properties in urine from calcium oxalate stone formers. J Urol 154:940–946
Tiselius HG (1991) Aspects on the risk of calcium oxalate crystallisation in urine. Urol Int 47:255–259
Nancollas GH (1983) Crystallization theory relating to urinary stone formation. World J Urol 1:131–137
Berg C, Tiselius HG (1989) The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals. Urol Res 17:167–172
Tiselius HG (2004) Recurrence prevention in patients with urinary tract stone disease. Scientific World Journal 31:417–425
Caudarella R, Vescini F (2009) Urinary citrate and renal stone disease: the preventive role of alkali treatment. Arch Ital Urol Androl 81:182–187
Cannon AB, Westropp JL, Ruby AL, Kass PH (2007) Evaluation of trends in urolith composition in cats: 5, 230 cases (1985–2004). J Am Vet Med Assoc 15:570–576
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tiselius, HG. A hypothesis of calcium stone formation: an interpretation of stone research during the past decades. Urol Res 39, 231–243 (2011). https://doi.org/10.1007/s00240-010-0349-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-010-0349-3